- Investing Ideas
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
Results
11
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
11 companies
Madrigal Pharmaceuticals
Market Cap: US$12.6b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$493.11
7D
-9.2%
1Y
63.0%
Vera Therapeutics
Market Cap: US$2.3b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases.
VERA
US$33.02
7D
-9.2%
1Y
58.8%
Iovance Biotherapeutics
Market Cap: US$2.0b
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.
IOVA
US$4.70
7D
-8.4%
1Y
82.9%
Syndax Pharmaceuticals
Market Cap: US$1.7b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$19.49
7D
-8.1%
1Y
96.5%
Canton Strategic Holdings
Market Cap: US$148.8m
Engages in the institutional blockchain adoption and digitization of financial markets in the United States.
CNTN
US$1.85
7D
-10.2%
1Y
48.6%
Cue Biopharma
Market Cap: US$117.7m
A clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders.
CUE
US$30.40
7D
-8.1%
1Y
35.0%
Kalaris Therapeutics
Market Cap: US$80.9m
A clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for prevalent retinal diseases.
KLRS
US$3.49
7D
-11.0%
1Y
30.2%
Clene
Market Cap: US$60.3m
A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics.
CLNN
US$5.01
7D
-8.6%
1Y
41.5%
Apollomics
Market Cap: US$38.4m
A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
APLM
US$17.35
7D
-8.0%
1Y
198.1%
Polyrizon
Market Cap: US$21.9m
A biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
PLRZ
US$11.60
7D
-24.2%
1Y
54.7%
Galera Therapeutics
Market Cap: US$16.2m
A biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer.
GRTX.D
US$15.62
7D
-10.7%
1Y
239.6%